You have 9 free searches left this month | for more free features.

City

Beni (1)

Butembo (1)

Freetown (1)

Mbandaka (1)

N'Zerekore (1)

Condition

Ebola Virus Disease (1)

Hemorrhagic Fever, Ebola (1)

Overall Status

Available (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

ANRS, Emerging Infectious Diseases (1)

Ridgeback Biotherapeutics, LP (1)

Collaborator

Institut National de Recherche Biomedicale. Kinshasa, Republique Democratique du Congo (1)

Intervention

ansuvimab (2)

ervebo (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (1)

Other (1)

Study Type

Expanded Access (1)

Interventional (1)

ansuvimab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hemorrhagic Fever, Ebola Trial in Congo, The Democratic Republic of the, Sierra Leone (Ansuvimab)

Available

Hemorrhagic Fever, Ebola

Ansuvimab

Mbandaka, Equateur, Congo, The Democratic Republic of the
+3 more

May 3, 2022

Ebola Virus Disease Trial in N'Zerekore (ansuvimab, Ervebo)

Not yet recruiting

Ebola Virus Disease

ansuvimab
Ervebo

N'Zerekore, Guinea

Centre de Traitement Ebola de N'Zerekore

Oct 14, 2021